Supernus Pharmaceuticals, Inc.
DE ˙ DB ˙ US8684591089
37,80 € 0,00 (0,00%)
2026-06-04
DELAT PRIS
SecurityDE:S49 / Supernus Pharmaceuticals, Inc.
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership106 shares
Latest Disclosed Value $ 5,479
IFP Advisors, Inc reports 0.93% decrease in ownership of S49 / Supernus Pharmaceuticals, Inc.

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 106 shares of Supernus Pharmaceuticals, Inc. (DE:S49) valued at $4,579 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 107 shares of Supernus Pharmaceuticals, Inc.. This represents a change in shares of -0.93% during the quarter. The current value of the position is $4,007 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 106 -1 -0.93 5 0.00 0.0001
2026-02-06 2025-12-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 107 0 0.00 5 0.00 0.0001
2026-02-06 2025-09-30 13F/A-1 SUPERNUS PHARMACEUTICALS INCCOM cs 868459108 107 1 0.94 5 66.67 0.0001
2025-12-02 2025-09-30 13F SUPERNUS PHARMACEUTICALS INCCOM cs 868459108 107 1 5 0.0001
2025-07-24 2025-06-30 13F SUPERNUS PHARMACEUTICALS cs 868459108 106 100 1,666.67 3 0.0001
2025-05-05 2025-03-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 6 0 0.00 0 0.0000
2025-02-04 2024-12-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 6 6 0 0.0000
2024-07-30 2024-03-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 0 -132 -100.00 0 -100.00
2024-01-09 2023-12-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 132 66 100.00 4 200.00 0.0002
2023-10-12 2023-09-30 13F SUPERNUS PHARMACEUTICALS cs 868459108 66 0 0.00 2 0.00 0.0001
2023-08-14 2023-06-30 13F/A-1 SUPERNUS PHARMACEUTICALS cs 868459108 66 0 0.00 2 -66.67 0.0001
2023-08-04 2023-06-30 13F SUPERNUS PHARMACEUTICALS cs 868459108 66 0 4 0.0002
2023-04-18 2023-03-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 66 -2,743 -97.65 4 0.0002
2023-02-07 2022-12-31 13F SUPERNUS PHARMACEUTICALS cs 868459108 2,809 -114 -3.90 0 -100.00 0.0042
2022-11-08 2022-09-30 13F SUPERNUS PHARMACEUTICALS cs 868459108 2,923 440 17.72 164 17.14 0.0043
2022-09-06 2022-06-30 13F/A-1 SUPERNUS PHARMACEUTICALS cs 868459108 2,483 0 0.00 140 0.00 0.0045
2022-09-06 2022-03-31 13F/A-1 SUPERNUS PHARMACEUTICALS cs 868459108 2,483 1,560 169.01 140 382.76 0.0045
2022-08-08 2022-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 939 16 53 0.0011
2022-01-12 2021-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 923 -23 -2.43 29 3.57 0.0006
2021-10-06 2021-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 946 762 414.13 28 366.67 0.0006
2021-07-13 2021-06-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 184 118 178.79 6 200.00 0.0001
2021-04-30 2021-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 66 66 2 0.0000
2021-01-25 2020-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2020-10-29 2020-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2020-08-05 2020-06-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2020-05-12 2020-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2020-01-17 2019-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2019-11-07 2019-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 0 0 0.0000
2019-05-15 2019-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 0 -1,759 -100.00 0 -100.00
2019-06-03 2018-12-31 13F/A-10 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 1,759 21 1.21 57 -35.23 0.0035
2019-01-23 2018-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 1,759 21 57 0.0035
2019-06-03 2018-09-30 13F/A-9 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 1,738 -785 -31.11 88 -41.72 0.0036
2018-10-25 2018-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 1,738 -785 88 0.0036
2019-06-03 2018-06-30 13F/A-8 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,523 437 20.95 151 81.93 0.0063
2018-08-07 2018-06-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,523 495 151
2019-06-03 2018-03-31 13F/A-7 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,086 0 0.00 83 0.00 0.0038
2018-05-09 2018-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,028 -58 93
2019-06-03 2017-12-31 13F/A-6 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,086 -925 -30.72 83 -30.83 0.0038
2018-01-24 2017-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,086 -925 83
2017-10-30 2017-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 3,011 507 20.25 120 11.11 0.0048
2019-06-03 2017-06-30 13F/A-5 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,504 -43 -1.69 108 35.00 0.0046
2017-07-31 2017-06-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,504 -43 108
2019-06-03 2017-03-31 13F/A-4 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,547 242 10.50 80 37.93 0.0035
2017-04-26 2017-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,547 242 80
2019-06-03 2016-12-31 13F/A-3 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,305 -68 -2.87 58 -1.69 0.0028
2017-02-14 2016-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,305 -68 58
2016-11-04 2016-09-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,373 -40 -1.66 59 20.41 0.0031
2019-06-03 2016-06-30 13F/A-2 SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,413 -49 -1.99 49 28.95 0.0027
2016-08-22 2016-06-30 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,413 -49 49
2016-05-02 2016-03-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,462 437 21.58 38 40.74 0.0023
2016-02-11 2015-12-31 13F SUPERNUS PHARMACEUTICALS INC COM Stock 868459108 2,025 2,025 27 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.